Tirzepatide
Metabolic HealthA dual GIP and GLP-1 receptor agonist studied in metabolic research.
- Area of care
- Metabolic Health
- Route of administration
- Subcutaneous injection, prescription only
- Regulatory status
- Approved medicine in several countries
- Evidence level
- Large randomised human trials
Suitability is determined by the clinic’s doctors.
Ask about a clinic referral